EDGEWELL PERSONAL CARE Co
No SEC Form 4 filings for $EPC in the last 30 days.
See all $EPC insider activity →Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.
Edgewell Personal Care (NYSE: EPC) reported Q2 CY2026 revenue of $570.1 million, up 1.7% year on year but below Wall Street estimates. Non-GAAP EPS was $0.72, 17.6% above consensus. The company cited improving organic net sales and North America performance. Shares were flat at $28.57 after the report.
Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.
Over the past 7 days, alphai's AI scored 5 news stories mentioning EPC (EDGEWELL PERSONAL CARE Co). Coverage has been balanced: 0 bullish, 5 neutral, and 0 bearish.
Recent EPC coverage spans earnings, market movers and financial news.
Q3 showed weaker operating income and GAAP EPS, while management guided to stronger Q4 via productivity and cycling prior one-time costs.
The miss on revenue and gross margin, despite EPS and EBITDA outperformance, creates a mixed near-term setup for EPC’s valuation and momentum.
Results show organic sales returning to growth and North America improving, but GAAP EPS fell and margins declined, implying a mixed near-term earnings quality signal.
Q3 showed improving North America organic sales and margin pressure, while GAAP EPS fell year over year and the company narrowed its full-year outlook.
The article frames EPC’s upcoming earnings against modest YoY revenue growth expectations (3%) after a prior-year decline, implying a near-term catalyst for the stock.
alphai scores every news story that mentions EPC with an AI model for sentiment and relevance, and aggregates insider trades from EDGEWELL PERSONAL CARE Co's SEC EDGAR Form 4 filings. Figures refresh continuously.
Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.
6 min readEdgewell Personal Care (NYSE: EPC) reported Q2 CY2026 revenue of $570.1 million, up 1.7% year on year but below Wall Street estimates. Non-GAAP EPS was $0.72, 17.6% above consensus. The company cited improving organic net sales and North America performance. Shares were flat at $28.57 after the report.
4 min readEdgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.
7 min readEDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26-epcexhibit991.htm EX-99.1 Document Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care A
4 min readEdgewell Personal Care (NYSE: EPC) is set to report earnings Wednesday before the bell. Last quarter, it met revenue expectations with $519.5 million, flat year over year, and beat analysts on EBITDA and organic revenue. For the upcoming quarter, analysts expect 3% revenue growth after a 13.5% decline. The average analyst price target is $28 versus $27.61.
2 min readEdgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.
4 min readMidday movers: Micron fell over 10% amid a broader tech selloff; Marvell slid 8% and Sandisk dropped 11%. Accenture rose nearly 2% after raising its buyback by $2B to over $7B. Flex fell over 2% after COO sold 36,000 shares. IBM gained over 4% after a JPMorgan overweight upgrade. Carnival dropped 6% on weaker Q3 guidance. AMC sank 25% on a planned 95.3M-share sale.
6 min readMahindra EPC Irrigation Ltd was awarded a contract to supply Micro Pressurized Irrigation Systems for 100 hectares under a community micro irrigation project, according to the Office of the Executive Engineer, Water Resources Division. The order is about Rs. 3.32 crore (including GST). The stock last traded on BSE at Rs. 104.90.
2 min readEdgewell Personal Care (NYSE:EPC) has issued its FY 2026 earnings guidance, projecting an EPS of $1.70 to $2.10, slightly above the consensus estimate of $1.90. The company anticipates revenue to be around the consensus estimate of $2.0 billion. Shares of EPC were up 6.2% at market open following the announcement, with analysts holding a "Hold" consensus rating and an average target price of $24.17.
2 min readEdgewell Personal Care's stock has risen by 20.6% in the last six months, outperforming the S&P 500, but faces significant financial risks. Analysts express caution due to flat organic revenue growth, a 6.4 percentage point decline in operating margin over the last year, and a high debt burden of $1.55 billion against only $223.3 million in cash. The company's net-debt-to-EBITDA ratio stands at 6x, indicating substantial leverage that could lead to increased borrowing costs if profitability continues to weaken.
2 min read
